<DOC>
	<DOCNO>NCT00215228</DOCNO>
	<brief_summary>Low heart rate variability marker increase risk cardiac mortality , observe depressed coronary artery disease patient . Some antidepressant may , however , decrease heart rate variability . We test hypothesis great reduction heart rate variability associate duloxetine ( noradrenergic activity ) escitalopram ( selective serotonin reuptake inhibitor ) . We also test hypothesis change heart rate variability relate magnitude norepinephrine transporter occupancy .</brief_summary>
	<brief_title>Effects Duloxetine vs. Escitalopram Heart Rate Variability Depression</brief_title>
	<detailed_description>Evaluation heart rate variability ( HRV ) show valuable tool measure autonomic dysfunction associate depression cardiac disease . Low HRV marker increase risk cardiac mortality , observe depressed coronary artery disease patient anxious patient post-MI . Treatment sympathomimetic antidepressant , MAO inhibitor tricyclic , reduce HRV , associate elevated heart rate , orthostatic hypotension , adverse cardiac event . Although increase evidence selective serotonin reuptake inhibitor ( SSRI ) class antidepressant minimal effect cardiovascular system , case less clear SNRI antidepressant block reuptake serotonin norepinephrine . It possible measure extent norepinephrine transporter blockade inhibition may relate HRV reduction see noradrenergic drug . Given consideration , propose study compare cardiovascular profile SSRI escitalopram ( Lexapro ) , recently available SNRI , duloxetine , outpatient depression . Using HRV methodology , test hypothesis great reduction HRV associate duloxetine escitalopram . In addition , measure magnitude serotonin norepinephrine transporter occupancy produce drug . This allow u examine relationship change HRV magnitude transporter inhibit effect drug .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>adult 2060 year age primary diagnosis depression use DSMIV criterion write informed consent negative serum pregnancy test woman childbearing potential history cardiovascular disease history hypertension history bipolar disorder history schizophrenia psychotic disorder alcohol substance abuse within last 3 month history cognitive impairment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>